ГОСТ 32437—2013
[22]EEC Council Directive 86/609/EEC on the approximation of laws, regulations and adminis
trative provisions of the Member States regarding the protection of animals used for experi
mental and other scientific purposes. Official Journal. 29. L358, 18th December 1986.
[23]National Research Council. 1985. Gutde for the care and use of laboratory animals. NIH
Publication No. 86-23. Washington D.C., US. Dept, of Health and Human Services.
[24]GV-SOLAS (Society for Laboratory Animal Science. Gesellschaft fur Versuchstierkunde,
1988). Publication on the Planning and Structure of Animal Facilities for Institutes Performing
Animal Experiments. ISBN 3-906255-04-2..
http://www.gv-solas.de/publ/heft1_1988.pdf
[25]GV-SOLAS (Society for Laboratory Animal Science. Gesellschaft fur Versuchstierkunde.
2006). Microbiological monitoring of laboratory animals in various housing systems.
http://www.gv-solas.de/auss/hyg/hyg-p7_e.html
[26]IPCS (1986). Principles and Methods for the Assessment of Neurotoxicity Associated with
Exposure to Chemicals. Environmental Health Criteria Document No. 60.
[27]Tupper. D.E., Wallace. R.B. (1980). Utility of the Neurologic Examination in Rats. Acta
Neurobiol. Exp.. 40. 999-1003.
[28] Gad. S.C. (1982). A Neuromuscular Screen for Use in Industrial Toxicology. J.
ToxicoI.Environ. Health. 9. 691-704.
[29]Moser. V.C.. McDaniel. K.M.. Phillips. P.M. (1991). Rat Strain and Stock Comparisons Using
a Functional Observational Battery: Baseline Values and Effects of Amitraz. Toxicol. Appl.
Pharmacol., 108. 267-283.
[30]29.Meyer O.A., Tilson H.A.. Byrd W.C.. Riley M.T. (1979). A Method for the RoutineAssess
ment of Fore- and Hind-limb Grip Strength of Rats and Mice. Neurobehav. Toxicol., 1, 233-
236.
[31]Draft consultant’s proposal. V. 8. OECD TG 452 November, 2008.14
[32]Crofton K.M.. Howard J.L., Moser V.C., Gill M.W.. Reiter L.W.. Tilson H.A., MacPhail R.C.
(1991). Intertaboratory Comparison of Motor Activity Experiments: Implication for Neurotoxi-
cological Assessments. Neurotoxicol. Teratol., 13. 599-609.
[33]Weingand K. Brown G. Hall R et al. (1996). Harmonisation of Animal Clinical Pathology Test
ing in Toxicity and Safety Studies. Fundam. & Appl. Toxicol.. 29: 198-201.
[34]EMEA (draft) document ’Non-clinical guideline on drug-induced hepatotoxicity’ (Doc. Ref.
EMEA/C HMP/S WP/a50115/2006)
[35]Crissman JW, Goodman DG. Hildebrandt PK et al. (2004). Best Practices Guideline: Toxico
logical Histopathology. Toxicologic Pathology 32.126-131.
10